Gossamer Bio
GOSS
123 hedge funds and large institutions have $502M invested in Gossamer Bio in 2021 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 44 reducing their positions, and 18 closing their positions.
11% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 18
1.89% more ownership
Funds ownership: 69.95% → 71.83% (+1.9%)
5% more call options, than puts
Call options by funds: $3.9M | Put options by funds: $3.73M
1% more funds holding
Funds holding: 122 → 123 (+1)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2% less capital invested
Capital invested by funds: $514M → $502M (-$11.7M)
18% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 44
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$11.4M |
| 2 |
BlackRock
New York
|
+$6.69M |
| 3 |
Two Sigma Investments
New York
|
+$5.34M |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$4.55M |
| 5 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$4.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$14.1M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$7.45M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
-$4.65M |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$2.85M |
| 5 |
Capital International Investors
Los Angeles,
California
|
-$2.1M |
GOSS Hedge Fund Activity: Q1 2021 in Review
123 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Gossamer Bio (GOSS) for Q1 2021, worth a combined $502M — down 2.3% from $514M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new GOSS positions and 18 closed out — a net gain of 2 holders — while 36 added to existing stakes and 44 trimmed.
The largest buyer was State Street, adding an estimated $11.4M. The largest seller was Jennison Associates, exiting entirely with an estimated $14.1M sold.
- 123 institutional investors held Gossamer Bio (GOSS) as of Q1 2021, up from 122 in Q4 2020.
- Funds reported $502M of Gossamer Bio stock for Q1 2021, down 2.3% quarter-over-quarter.
- 20 funds opened new Gossamer Bio positions in Q1 2021 and 18 closed out, a net change of +2 holders.
- The largest Gossamer Bio buyer in Q1 2021 was State Street, an estimated $11.4M added.
- The largest Gossamer Bio seller in Q1 2021 was Jennison Associates, an estimated $14.1M sold.
Based on aggregated 13F filings for Q1 2021.